DK0469348T3 - cDNA-sekvens og detektering af hepatitis C-virus - Google Patents

cDNA-sekvens og detektering af hepatitis C-virus

Info

Publication number
DK0469348T3
DK0469348T3 DK91111413.0T DK91111413T DK0469348T3 DK 0469348 T3 DK0469348 T3 DK 0469348T3 DK 91111413 T DK91111413 T DK 91111413T DK 0469348 T3 DK0469348 T3 DK 0469348T3
Authority
DK
Denmark
Prior art keywords
hepatitis
virus
detection
cdna sequence
pcr technique
Prior art date
Application number
DK91111413.0T
Other languages
Danish (da)
English (en)
Inventor
Takenobu Kamada
Norio Hayashi
Eiji Mita
Keiji Ueda
Original Assignee
Shionogi & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP41217790A external-priority patent/JPH04218376A/ja
Priority claimed from JP2936491A external-priority patent/JPH04218377A/ja
Priority claimed from JP4285591A external-priority patent/JPH04262784A/ja
Application filed by Shionogi & Co filed Critical Shionogi & Co
Application granted granted Critical
Publication of DK0469348T3 publication Critical patent/DK0469348T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C12Q1/706—Specific hybridization probes for hepatitis
    • C12Q1/707—Specific hybridization probes for hepatitis non-A, non-B Hepatitis, excluding hepatitis D
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
    • C12N2770/24222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • Wood Science & Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DK91111413.0T 1990-07-11 1991-07-09 cDNA-sekvens og detektering af hepatitis C-virus DK0469348T3 (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP18351290 1990-07-11
JP41217790A JPH04218376A (ja) 1990-12-18 1990-12-18 Ｃ型肝炎ウィルスのｃＤＮＡ配列
JP2936491A JPH04218377A (ja) 1990-07-11 1991-01-30 Ｃ型肝炎ウイルスのｃＤＮＡ配列および検出方法
JP4285591A JPH04262784A (ja) 1991-02-14 1991-02-14 Ｃ型肝炎ウイルスのｃＤＮＡ配列および検出方法

Publications (1)

Publication Number Publication Date
DK0469348T3 true DK0469348T3 (da) 1997-04-01

Family

ID=27459049

Family Applications (1)

Application Number Title Priority Date Filing Date
DK91111413.0T DK0469348T3 (da) 1990-07-11 1991-07-09 cDNA-sekvens og detektering af hepatitis C-virus

Country Status (6)

Country Link
EP (1) EP0469348B1 (es)
AT (1) ATE150086T1 (es)
DE (1) DE69125066T2 (es)
DK (1) DK0469348T3 (es)
ES (1) ES2100185T3 (es)
GR (1) GR3023251T3 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL169035B1 (pl) * 1990-08-10 1996-05-31 Chiron Corp Sposób wykrywania sekwencji HCV PL
DK0529493T3 (da) * 1991-08-27 1998-08-24 Hoffmann La Roche Fremgangsmåder og reagenser til hepatitis C-detektion
ES2044784B1 (es) * 1992-06-12 1994-09-01 Inia Procedimiento para la deteccion e identificacion de patogenos virales y subvirales.
DE69334357D1 (de) 1992-11-27 2011-06-09 Innogenetics Nv Nachweis und Typisierung das Hepatitis C Virus (HCV) mittels 5'UTR und NS5 Nukleinsäuresequenzen
US7258977B1 (en) 1992-11-27 2007-08-21 Innogenetics N.V. Process for typing of HCV isolates
US5851759A (en) * 1996-04-19 1998-12-22 Chiron Corporation Heteroduplex tracking assay (HTA) for genotyping HCV
US7196183B2 (en) 2001-08-31 2007-03-27 Innogenetics N.V. Hepatitis C virus genotype, and its use as prophylactic, therapeutic and diagnostic agent
US8124747B2 (en) 2003-08-29 2012-02-28 Innogenetics HCV clade and prototype sequences thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ227011A (en) * 1987-11-18 1992-03-26 Chiron Corp Non-a, non-b-hepatitis (hepatitis c) antigens, proteins, nucleotide sequences, vaccines and kits
HUT54896A (en) * 1989-03-17 1991-04-29 Chiron Corp Process for producing aquous diagnosticum and vaccine of nanbv
EP0398748B1 (en) * 1989-05-18 2002-01-09 Chiron Corporation NANBV diagnostics: polynucleotides useful for screening for hepatitis C virus
CA2065287C (en) * 1989-09-15 1999-12-21 Tatsuo Miyamura New hcv isolates

Also Published As

Publication number Publication date
EP0469348A2 (en) 1992-02-05
EP0469348B1 (en) 1997-03-12
EP0469348A3 (en) 1992-02-12
GR3023251T3 (en) 1997-07-30
ATE150086T1 (de) 1997-03-15
DE69125066T2 (de) 1997-09-25
DE69125066D1 (de) 1997-04-17
ES2100185T3 (es) 1997-06-16

Similar Documents

Publication Publication Date Title
DE69232906T2 (de) Detektion des Hepatis-C Virus.
DK0935660T3 (da) Infektiöse kloner af RNA-virusser og vacciner og deraf afledte diagnostiske assays
ATE552340T1 (de) Hepatitis c virus genotypsequenzen sowie ihre verwendung als behandlungs- und nachweismitteln
ES2188583T3 (es) Polipeptidos para el virus de la hepatitis c (hcv).
DK0725824T3 (da) Immunodominante humane T-celleepitoper af hepatitis C virus
DK118887A (da) Fremgangsmaade til indvinding af mikrobielt produceret, rekombinant, oploeseligt ricintoxin-a-kaede
DK0484787T3 (da) HCV-specifikke peptider, fremgangsmåde til opnåelse deraf og anvendelse deraf
DK0637342T3 (da) Fremgangsmåde til typebestemmelse af HCV-isolater
DE68903165D1 (de) Rns des genoms des non-a, non-b-hepatitisvirus und antigenisches virales protein.
DK158475C (da) Fremgangsmaade til fremstilling af interferon eller en interferonoploesning fra interferonproducerende bakterier.
DK166087A (da) Htlv-iii-virusprotein, dna-sekvens, der koder herfor, fremgangsmaade til fremstilling heraf, fremgangsmaade til detektion af aids-virus samt antistoffer mod aids-virus
DK464578A (da) Fremgangsmaade til fremstilling af 3-substituerede og 6-substituerede 7-oxo-1-azabicyclo (3,2,0) hept-2-en-2-carxylsyrer eller amiier deraf
DE68927025D1 (de) HIV-2-Virusvarianten
DK0405867T3 (da) Hidtil ukendte forbindelser
DK0698216T3 (da) Fremgangsmåder til typebestemmelse af hepatitis-C-virus og anvendte reagenser
DK0469348T3 (da) cDNA-sekvens og detektering af hepatitis C-virus
DK0672192T3 (da) Fremgangsmåde til inhibering af virusmorfogenese
PH31116A (en) Methods for the treatment of infection caused by hepatitis B virus (hbv).
DK495786A (da) Fremgangsmaade til fremstilling af halogen-magnesium-alanat og alanatets anvendelse
DK150597C (da) Analogifremgangsmaade til fremstilling af 3,4-bis-substituerede 1,2,5-oxadiazol-2-oxider eller farmakologisk acceptable syreadditionssalte deraf
DK498387D0 (da) Virus-dna-sekvens
DK192890D0 (da) 24r-scumnol, fremgangsmaade til fremstilling heraf samt anvendelse af samme
DK260482A (da) Fremgangsmaade til fremstilling af rent hepatitis b overfladeantigen ud fra human plasma
DK604783A (da) Fremgangsmaade til fremstilling af et funktionelt hydrolysat ud fra mikrobielle proteinisolater
DK379385D0 (da) Fremgangsmaade til paavisning af infektioes aids-virus